Position in DTIL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$164,274
+$121,202 QoQ
Shares Held
20,900
+101.9% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 95 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. DTIL ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in DTIL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,274 | 20,900 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $43,072 | 10,354 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $11,205 | 30,699 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,468 | 30,699 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,147 | 30,699 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,587 | 24,652 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,179 | 30,403 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $37,569 | 28,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $63,422 | 39,639 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||